258 related articles for article (PubMed ID: 34200285)
1. The Hippo Pathway: A Master Regulatory Network Important in Cancer.
Liu Q; Liu X; Song G
Cells; 2021 Jun; 10(6):. PubMed ID: 34200285
[TBL] [Abstract][Full Text] [Related]
2. Hippo pathway: Regulation, deregulation and potential therapeutic targets in cancer.
Mohajan S; Jaiswal PK; Vatanmakarian M; Yousefi H; Sankaralingam S; Alahari SK; Koul S; Koul HK
Cancer Lett; 2021 Jun; 507():112-123. PubMed ID: 33737002
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the role of the Hippo pathway in cancer.
Han Y
J Transl Med; 2019 Apr; 17(1):116. PubMed ID: 30961610
[TBL] [Abstract][Full Text] [Related]
4. Upregulated microRNA miR-21 promotes the progression of lung adenocarcinoma through inhibition of KIBRA and the Hippo signaling pathway.
An Y; Zhang Q; Li X; Wang Z; Li Y; Tang X
Biomed Pharmacother; 2018 Dec; 108():1845-1855. PubMed ID: 30372890
[TBL] [Abstract][Full Text] [Related]
5. The roles of the Hippo pathway in cancer metastasis.
Janse van Rensburg HJ; Yang X
Cell Signal; 2016 Nov; 28(11):1761-72. PubMed ID: 27519476
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the Hippo-YAP Pathway by Glucose Sensor O-GlcNAcylation.
Peng C; Zhu Y; Zhang W; Liao Q; Chen Y; Zhao X; Guo Q; Shen P; Zhen B; Qian X; Yang D; Zhang JS; Xiao D; Qin W; Pei H
Mol Cell; 2017 Nov; 68(3):591-604.e5. PubMed ID: 29100056
[TBL] [Abstract][Full Text] [Related]
7. New insights into the core Hippo signaling and biological macromolecules interactions in the biology of solid tumors.
Mohammadi S; Arefnezhad R; Danaii S; Yousefi M
Biofactors; 2020 Jul; 46(4):514-530. PubMed ID: 32445262
[TBL] [Abstract][Full Text] [Related]
8. Hippo Pathway in Cancer: Aberrant Regulation and Therapeutic Opportunities.
Calses PC; Crawford JJ; Lill JR; Dey A
Trends Cancer; 2019 May; 5(5):297-307. PubMed ID: 31174842
[TBL] [Abstract][Full Text] [Related]
9. The Hippo Pathway and YAP Signaling: Emerging Concepts in Regulation, Signaling, and Experimental Targeting Strategies With Implications for Hepatobiliary Malignancies.
Werneburg N; Gores GJ; Smoot RL
Gene Expr; 2020 Jun; 20(1):67-74. PubMed ID: 31253203
[TBL] [Abstract][Full Text] [Related]
10. The Hippo Pathway as a Driver of Select Human Cancers.
Kulkarni A; Chang MT; Vissers JHA; Dey A; Harvey KF
Trends Cancer; 2020 Sep; 6(9):781-796. PubMed ID: 32446746
[TBL] [Abstract][Full Text] [Related]
11. Rheb may complex with RASSF1A to coordinate Hippo and TOR signaling.
Nelson N; Clark GJ
Oncotarget; 2016 Jun; 7(23):33821-31. PubMed ID: 27034171
[TBL] [Abstract][Full Text] [Related]
12. Reconstruction of the genome-scale co-expression network for the Hippo signaling pathway in colorectal cancer.
Dehghanian F; Hojati Z; Hosseinkhan N; Mousavian Z; Masoudi-Nejad A
Comput Biol Med; 2018 Aug; 99():76-84. PubMed ID: 29890510
[TBL] [Abstract][Full Text] [Related]
13. Hippo pathway in mammary gland development and breast cancer.
Shi P; Feng J; Chen C
Acta Biochim Biophys Sin (Shanghai); 2015 Jan; 47(1):53-9. PubMed ID: 25467757
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of ERK1/2 down-regulates the Hippo/YAP signaling pathway in human NSCLC cells.
You B; Yang YL; Xu Z; Dai Y; Liu S; Mao JH; Tetsu O; Li H; Jablons DM; You L
Oncotarget; 2015 Feb; 6(6):4357-68. PubMed ID: 25738359
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the Hippo pathway and implications for anticancer drug development.
Park HW; Guan KL
Trends Pharmacol Sci; 2013 Oct; 34(10):581-9. PubMed ID: 24051213
[TBL] [Abstract][Full Text] [Related]
16. Targeting the Hippo pathway: Clinical implications and therapeutics.
Ye S; Eisinger-Mathason TS
Pharmacol Res; 2016 Jan; 103():270-8. PubMed ID: 26678601
[TBL] [Abstract][Full Text] [Related]
17. Regulatory role of microRNAs in cancer through Hippo signaling pathway.
Astamal RV; Maghoul A; Taefehshokr S; Bagheri T; Mikaeili E; Derakhshani A; Delashoub M; Taefehshokr N; Isazadeh A; Hajazimian S; Tran A; Baradaran B
Pathol Res Pract; 2020 Dec; 216(12):153241. PubMed ID: 33065484
[TBL] [Abstract][Full Text] [Related]
18. Molecular Pathways: Hippo Signaling, a Critical Tumor Suppressor.
Sebio A; Lenz HJ
Clin Cancer Res; 2015 Nov; 21(22):5002-7. PubMed ID: 26384319
[TBL] [Abstract][Full Text] [Related]
19. Two faces of Hippo: activate or suppress the Hippo pathway in cancer.
Cao J; Huang W
Anticancer Drugs; 2017 Nov; 28(10):1079-1085. PubMed ID: 28926422
[TBL] [Abstract][Full Text] [Related]
20. Emerging role of Hippo signalling pathway in bladder cancer.
Xia J; Zeng M; Zhu H; Chen X; Weng Z; Li S
J Cell Mol Med; 2018 Jan; 22(1):4-15. PubMed ID: 28782275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
